{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:41:15Z","timestamp":1792431675805,"version":"4.5.0"},"reference-count":129,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015615","name":"National Institute on Drug Abuse Clinical Trials Network","doi-asserted-by":"publisher","award":["UG1DA040309"],"award-info":[{"award-number":["UG1DA040309"]}],"id":[{"id":"10.13039\/100015615","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.josat.2026.210065","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T23:50:16Z","timestamp":1782949816000},"page":"210065","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Methodological innovations to advance substance use disorder research: Proceedings of a NIDA workshop on target trial emulation and translational testing of digital health tools"],"prefix":"10.1016","volume":"190","author":[{"given":"Luke C.","family":"Hall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie M.","family":"Donohue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"LaRochelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca C.","family":"Rossom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Afshar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walid F.","family":"Gellad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf H.H.","family":"Groenwold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Hsuan","family":"Lo-Ciganic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Lodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon D.L.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany M.","family":"McLeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal A.","family":"Lambert-Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth C.","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Marsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.josat.2026.210065_bb0005","author":"(CDC) CfDCaP"},{"key":"10.1016\/j.josat.2026.210065_bb0010","author":"(SAMHSA) SAaMHS"},{"key":"10.1016\/j.josat.2026.210065_bb0015","author":"Administration SAaMHS"},{"key":"10.1016\/j.josat.2026.210065_bb0020","series-title":"National Survey on Drug Use and Health (NSDUH) supporting statement","author":"Administration SAaMHS","year":"2024"},{"key":"10.1016\/j.josat.2026.210065_bb0025","series-title":"2021 methodological summary and definitions","author":"Administration SUaMHS","year":"2023"},{"key":"10.1016\/j.josat.2026.210065_bb0030","doi-asserted-by":"crossref","DOI":"10.2196\/44977","article-title":"Deployment of real-time natural language processing and deep learning clinical decision support in the electronic health record: Pipeline implementation for an opioid misuse screener in hospitalized adults","volume":"11","author":"Afshar","year":"2023","journal-title":"JMIR Medical Informatics"},{"issue":"11","key":"10.1016\/j.josat.2026.210065_bb0035","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/jamia\/ocz068","article-title":"Development and application of a high throughput natural language processing architecture to convert all clinical documents in a clinical data warehouse into standardized medical vocabularies","volume":"26","author":"Afshar","year":"2019","journal-title":"Journal of the American Medical Informatics Association"},{"issue":"6","key":"10.1016\/j.josat.2026.210065_bb0040","doi-asserted-by":"crossref","first-page":"e426","DOI":"10.1016\/S2589-7500(22)00041-3","article-title":"Development and multimodal validation of a substance misuse algorithm for referral to treatment using artificial intelligence (SMART-AI): A retrospective deep learning study","volume":"4","author":"Afshar","year":"2022","journal-title":"Lancet Digital Health"},{"issue":"10","key":"10.1016\/j.josat.2026.210065_bb0045","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1093\/aje\/kwad119","article-title":"Translating predictive analytics for public health practice: A case study of overdose prevention in Rhode Island","volume":"192","author":"Allen","year":"2023","journal-title":"American Journal of Epidemiology"},{"issue":"1","key":"10.1016\/j.josat.2026.210065_bb0050","article-title":"Target trial emulation: A concept simply explained","volume":"86","author":"Andrade","year":"2025","journal-title":"Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1016\/j.josat.2026.210065_bb0055","doi-asserted-by":"crossref","DOI":"10.1186\/s13722-020-0180-2","article-title":"Developing a clinical decision support for opioid use disorders: A NIDA Center for the Clinical Trials Network Working Group report","volume":"15","author":"Bart","year":"2020","journal-title":"Addiction Science & Clinical Practice"},{"issue":"10","key":"10.1016\/j.josat.2026.210065_bb0060","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/pds.4932","article-title":"Trial designs using real-world data: The changing landscape of the regulatory approval process","volume":"29","author":"Baumfeld Andre","year":"2020","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"1\u20133","key":"10.1016\/j.josat.2026.210065_bb0065","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.drugalcdep.2007.09.018","article-title":"Non-medical use, abuse and dependence on prescription opioids among U.S. adults: Psychiatric, medical and substance use correlates","volume":"94","author":"Becker","year":"2008","journal-title":"Drug and Alcohol Dependence"},{"issue":"13","key":"10.1016\/j.josat.2026.210065_bb0070","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1001\/jama.2011.370","article-title":"Association between opioid prescribing patterns and opioid overdose-related deaths","volume":"305","author":"Bohnert","year":"2011","journal-title":"Jama"},{"key":"10.1016\/j.josat.2026.210065_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103677","article-title":"Fatal overdose: Predicting to prevent","volume":"104","author":"Borquez","year":"2022","journal-title":"The International Journal on Drug Policy"},{"issue":"10","key":"10.1016\/j.josat.2026.210065_bb0080","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/pds.4975","article-title":"Real-world evidence to support regulatory decision-making for medicines: Considerations for external control arms","volume":"29","author":"Burcu","year":"2020","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"12","key":"10.1016\/j.josat.2026.210065_bb0085","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/pds.1659","article-title":"National addictions vigilance intervention and prevention program (NAVIPPRO): A real-time, product-specific, public health surveillance system for monitoring prescription drug abuse","volume":"17","author":"Butler","year":"2008","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"12","key":"10.1016\/j.josat.2026.210065_bb0090","doi-asserted-by":"crossref","first-page":"837","DOI":"10.7326\/M17-3065","article-title":"Patterns of potential opioid misuse and subsequent adverse outcomes in Medicare, 2008 to 2012","volume":"168","author":"Carey","year":"2018","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.josat.2026.210065_bb0095","author":"Centers for Disease Control and Prevention (CDC)"},{"key":"10.1016\/j.josat.2026.210065_bb0100","author":"Centers for Disease Control and Prevention (CDC)"},{"key":"10.1016\/j.josat.2026.210065_bb0105","author":"Centers for Disease Control and Prevention (CDC)"},{"key":"10.1016\/j.josat.2026.210065_bb0110","author":"Centers for Medicare and Medicaid Services (CMS)"},{"issue":"4","key":"10.1016\/j.josat.2026.210065_bb0115","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2165\/11596600-000000000-00000","article-title":"Assessing opioid shopping behaviour: A large cohort study from a medication dispensing database in the US","volume":"35","author":"Cepeda","year":"2012","journal-title":"Drug Safety"},{"key":"10.1016\/j.josat.2026.210065_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2023.104370","article-title":"Contextualized medication information extraction using Transformer-based deep learning architectures","volume":"142","author":"Chen","year":"2023","journal-title":"Journal of Biomedical Informatics"},{"issue":"7","key":"10.1016\/j.josat.2026.210065_bb0125","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1111\/add.16473","article-title":"Target trial emulation for comparative effectiveness research with observational data: Promise and challenges for studying medications for opioid use disorder","volume":"119","author":"Christine","year":"2024","journal-title":"Addiction"},{"key":"10.1016\/j.josat.2026.210065_bb0130","doi-asserted-by":"crossref","DOI":"10.1111\/add.70327","article-title":"Target trial emulation for addiction research\u2014A useful method but not a panacea","author":"Clare","year":"2026","journal-title":"Addiction"},{"key":"10.1016\/j.josat.2026.210065_bb0135","author":"ClinicalTrials.gov"},{"issue":"3","key":"10.1016\/j.josat.2026.210065_bb0140","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/MLR.0000000000000676","article-title":"An examination of claims-based predictors of overdose from a large Medicaid program","volume":"55","author":"Cochran","year":"2017","journal-title":"Medical Care"},{"key":"10.1016\/j.josat.2026.210065_bb0145","series-title":"Planning and analysis of observational studies","author":"Cochran","year":"2009"},{"issue":"2","key":"10.1016\/j.josat.2026.210065_bb0150","doi-asserted-by":"crossref","first-page":"234","DOI":"10.2307\/2344179","article-title":"The planning of observational studies of human populations","volume":"128","author":"Cochran","year":"1965","journal-title":"Journal of the Royal Statistical Society. Series A (General)"},{"issue":"4","key":"10.1016\/j.josat.2026.210065_bb0155","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1176\/appi.ajp.2009.09081087","article-title":"The effect of inmate populations on estimates of DSM-IV alcohol and drug use disorders in the United States","volume":"167","author":"Compton","year":"2010","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.josat.2026.210065_bb0160","doi-asserted-by":"crossref","DOI":"10.1002\/oby.70024","article-title":"GLP-1 receptor agonists and substance use disorders in older adults with type 2 diabetes: A target trial emulation","author":"Dai","year":"2025","journal-title":"Obesity (Silver Spring)"},{"issue":"Suppl. 1","key":"10.1016\/j.josat.2026.210065_bb0165","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/BOT.0000000000002039","article-title":"Leveraging real-world evidence: A paradigm shift in regulation","volume":"35","author":"De","year":"2021","journal-title":"Journal of Orthopaedic Trauma"},{"issue":"2","key":"10.1016\/j.josat.2026.210065_bb0170","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1056\/NEJMoa2115463","article-title":"Comparative effectiveness of BNT162b2 and mRNA-1273 vaccines in U.S. Veterans","volume":"386","author":"Dickerman","year":"2022","journal-title":"The New England Journal of Medicine"},{"issue":"6 Pt 1","key":"10.1016\/j.josat.2026.210065_bb0175","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2105\/AJPH.43.6_Pt_1.677","article-title":"Philosophy of inferences from retrospective studies","volume":"43","author":"Dorn","year":"1953","journal-title":"American Journal of Public Health and the Nation\u2019s Health"},{"issue":"3","key":"10.1016\/j.josat.2026.210065_bb0180","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2025-113432","article-title":"Patient and public involvement and engagement in target trial emulation framework: A scoping review protocol","volume":"16","author":"Egesa","year":"2026","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.josat.2026.210065_bb0185","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1002\/cpt.2083","article-title":"Randomized controlled trials versus real world evidence: Neither magic nor myth","volume":"109","author":"Eichler","year":"2021","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.josat.2026.210065_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.pmedr.2022.101847","article-title":"The Massachusetts public health data warehouse and the opioid epidemic: A qualitative study of perceived strengths and limitations for advancing research","volume":"28","author":"Evans","year":"2022","journal-title":"Preventive Medical Reports"},{"issue":"6","key":"10.1016\/j.josat.2026.210065_bb0195","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0895-4356(89)90142-X","article-title":"Epidemiologic analyses of causation: The unlearned scientific lessons of randomized trials","volume":"42","author":"Feinstein","year":"1989","journal-title":"Journal of Clinical Epidemiology"},{"issue":"8","key":"10.1016\/j.josat.2026.210065_bb0200","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1681\/ASN.0000000000000152","article-title":"Target trial emulation to improve causal inference from observational data: What, why, and how?","volume":"34","author":"Fu","year":"2023","journal-title":"Journal of the American Society of Nephrology"},{"issue":"10","key":"10.1016\/j.josat.2026.210065_bb0205","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1007\/s11606-017-4288-3","article-title":"Prediction model for two-year risk of opioid overdose among patients prescribed chronic opioid therapy","volume":"33","author":"Glanz","year":"2018","journal-title":"Journal of General Internal Medicine"},{"issue":"3","key":"10.1016\/j.josat.2026.210065_bb0210","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s40429-020-00318-8","article-title":"Wearable and wireless mhealth technologies for substance use disorder","volume":"7","author":"Goldfine","year":"2020","journal-title":"Current Addiction Reports"},{"issue":"5","key":"10.1016\/j.josat.2026.210065_bb0215","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1001\/jamainternmed.2013.12711","article-title":"High-risk use by patients prescribed opioids for pain and its role in overdose deaths","volume":"174","author":"Gwira Baumblatt","year":"2014","journal-title":"JAMA Internal Medicine"},{"issue":"22","key":"10.1016\/j.josat.2026.210065_bb0220","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1001\/jama.2008.802","article-title":"Patterns of abuse among unintentional pharmaceutical overdose fatalities","volume":"300","author":"Hall","year":"2008","journal-title":"The Journal of the American Medical Association."},{"issue":"13","key":"10.1016\/j.josat.2026.210065_bb0225","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1056\/NEJMsb071595","article-title":"Harnessing the power of default options to improve health care","volume":"357","author":"Halpern","year":"2007","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.josat.2026.210065_bb0230","series-title":"Key substance use and mental health indicators in the United States: Results from the 2019 National Survey on Drug Use and Health","author":"Han","year":"2020"},{"issue":"5","key":"10.1016\/j.josat.2026.210065_bb0235","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/M17-0865","article-title":"Prescription opioid use, misuse, and use disorders in U.S. adults: 2015 National Survey on Drug Use and Health","volume":"167","author":"Han","year":"2017","journal-title":"Annals of Internal Medicine"},{"issue":"12","key":"10.1016\/j.josat.2026.210065_bb0240","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1001\/jamapsychiatry.2021.2588","article-title":"Methamphetamine use, methamphetamine use disorder, and associated overdose deaths among US adults","volume":"78","author":"Han","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"8","key":"10.1016\/j.josat.2026.210065_bb0245","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/jamapsychiatry.2021.1271","article-title":"Use of medications for alcohol use disorder in the US: Results from the 2019 National Survey on Drug Use and Health","volume":"78","author":"Han","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.josat.2026.210065_bb0250","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jpsychires.2016.03.002","article-title":"Estimating the rates of deaths by suicide among adults who attempt suicide in the United States","volume":"77","author":"Han","year":"2016","journal-title":"Journal of Psychiatric Research"},{"issue":"9","key":"10.1016\/j.josat.2026.210065_bb0255","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-074626","article-title":"Development of the TrAnsparent ReportinG of observational studies Emulating a Target trial (TARGET) guideline","volume":"13","author":"Hansford","year":"2023","journal-title":"BMJ Open"},{"issue":"13","key":"10.1016\/j.josat.2026.210065_bb0260","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1111\/1471-0528.15199","article-title":"Randomised controlled trials - the gold standard for effectiveness research: Study design: Randomised controlled trials","volume":"125","author":"Hariton","year":"2018","journal-title":"BJOG\u202f: An International Journal of Obstetrics and Gynaecology"},{"key":"10.1016\/j.josat.2026.210065_bb0265","author":"Health D"},{"key":"10.1016\/j.josat.2026.210065_bb0270","author":"Health UoMSoP"},{"issue":"3","key":"10.1016\/j.josat.2026.210065_bb0275","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/aje\/kwae098","article-title":"Evaluating the effectiveness of systemic heparin during arteriovenous fistula creation by emulating a target trial","volume":"194","author":"Heindel","year":"2025","journal-title":"American Journal of Epidemiology"},{"issue":"8","key":"10.1016\/j.josat.2026.210065_bb0280","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/aje\/kwv254","article-title":"Using Big Data to emulate a target trial when a randomized trial is not available","volume":"183","author":"Hern\u00e1n","year":"2016","journal-title":"American Journal of Epidemiology"},{"issue":"24","key":"10.1016\/j.josat.2026.210065_bb0285","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1001\/jama.2022.21383","article-title":"Target trial emulation: A framework for causal inference from observational data","volume":"328","author":"Hern\u00e1n","year":"2022","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.josat.2026.210065_bb0290","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1093\/jamia\/ocab221","article-title":"The OneFlorida Data Trust: A centralized, translational research data infrastructure of statewide scope","volume":"29","author":"Hogan","year":"2022","journal-title":"Journal of the American Medical Informatics Association"},{"issue":"23","key":"10.1016\/j.josat.2026.210065_bb0295","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14238522","article-title":"Protocol for a single-arm pilot clinical trial: Developing and Evaluating a Machine Learning Opioid Prediction & Risk-Stratification E-Platform (DEMONSTRATE)","volume":"14","author":"Hong","year":"2025","journal-title":"Journal of Clinical Medicine"},{"issue":"3","key":"10.1016\/j.josat.2026.210065_bb0300","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-095198","article-title":"Comparative effectiveness of methadone take-home dose initiation in British Columbia, Canada: Protocol for a population-based retrospective cohort study using target trial guidelines","volume":"15","author":"Hossain","year":"2025","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.josat.2026.210065_bb0305","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jpain.2015.01.011","article-title":"Automated prediction of risk for problem opioid use in a primary care setting","volume":"16","author":"Hylan","year":"2015","journal-title":"The Journal of Pain"},{"key":"10.1016\/j.josat.2026.210065_bb0310","series-title":"Bridging the gap between practice and research: Forging partnerships with community-based drug and alcohol treatment","author":"Institute of Medicine Committee on Community-Based Drug T","year":"1998"},{"key":"10.1016\/j.josat.2026.210065_bb0315","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1472-6963-6-46","article-title":"Predictors of opioid misuse in patients with chronic pain: A prospective cohort study","volume":"6","author":"Ives","year":"2006","journal-title":"BMC Health Services Research"},{"issue":"3","key":"10.1016\/j.josat.2026.210065_bb0320","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/jnci\/djaa110","article-title":"Temporal trends in opioid prescribing patterns among oncologists in the Medicare population","volume":"113","author":"Jairam","year":"2021","journal-title":"Journal of the National Cancer Institute"},{"issue":"6","key":"10.1016\/j.josat.2026.210065_bb0325","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/cpt.3218","article-title":"Real-world evidence to inform regulatory decision making: A scoping review","volume":"115","author":"Jansen","year":"2024","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"1","key":"10.1016\/j.josat.2026.210065_bb0330","doi-asserted-by":"crossref","DOI":"10.1002\/pds.70074","article-title":"Multiple perspectives on the need for real-world evidence to inform regulatory and health technology assessment decision-making: Scoping review and stakeholder interviews","volume":"34","author":"Jansen","year":"2025","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"5","key":"10.1016\/j.josat.2026.210065_bb0335","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1001\/jamapsychiatry.2023.0310","article-title":"Association of receipt of opioid use disorder-related telehealth services and medications for opioid use disorder with fatal drug overdoses among Medicare beneficiaries before and during the COVID-19 pandemic","volume":"80","author":"Jones","year":"2023","journal-title":"JAMA Psychiatry"},{"issue":"10","key":"10.1016\/j.josat.2026.210065_bb0340","article-title":"A comprehensive literature review of digital health interventions in the treatment of substance use disorder with special focus on mobile applications","volume":"15","author":"Jordan","year":"2023","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.josat.2026.210065_bb0345","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1257\/jep.5.1.193","article-title":"Anomalies: The endowment effect, loss aversion, and status quo Bias","volume":"5","author":"Kahneman","year":"1991","journal-title":"Journal of Economic Perspectives"},{"issue":"5","key":"10.1016\/j.josat.2026.210065_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.focus.2024.100258","article-title":"Associations between reductions in depressive symptoms and reductions in pain and anxiety symptoms and substance use: Emulation of a randomized trial","volume":"3","author":"Khan","year":"2024","journal-title":"AJPM Focus."},{"issue":"7","key":"10.1016\/j.josat.2026.210065_bb0355","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2022.2263","article-title":"Effect of different interventions to help primary care clinicians avoid unsafe opioid prescribing in opioid-naive patients with acute noncancer pain: A cluster randomized clinical trial","volume":"3","author":"Kraemer","year":"2022","journal-title":"JAMA Health Forum."},{"issue":"10","key":"10.1016\/j.josat.2026.210065_bb0360","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-098317","article-title":"Comparative effectiveness of take-home dosing schedules for opioid agonist treatment in British Columbia, Canada: A target trial emulation protocol using a population-based observational study","volume":"15","author":"Kurz","year":"2025","journal-title":"BMJ Open"},{"issue":"12","key":"10.1016\/j.josat.2026.210065_bb0365","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1111\/add.70171","article-title":"Comparative effectiveness of urine drug testing schedules alongside opioid agonist treatment: Emulation of a population-based target trial in British Columbia, Canada","volume":"120","author":"Kurz","year":"2025","journal-title":"Addiction"},{"issue":"8","key":"10.1016\/j.josat.2026.210065_bb0370","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.26523","article-title":"Comparative effectiveness of opioid tapering or abrupt discontinuation vs no dosage change for opioid overdose or suicide for patients receiving stable long-term opioid therapy","volume":"5","author":"Larochelle","year":"2022","journal-title":"JAMA Network Open"},{"issue":"10118","key":"10.1016\/j.josat.2026.210065_bb0375","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(17)32812-X","article-title":"Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): A multicentre, open-label, randomised controlled trial","volume":"391","author":"Lee","year":"2018","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.josat.2026.210065_bb0380","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0248360","article-title":"Integrating human services and criminal justice data with claims data to predict risk of opioid overdose among Medicaid beneficiaries: A machine-learning approach","volume":"16","author":"Lo-Ciganic","year":"2021","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.josat.2026.210065_bb0385","doi-asserted-by":"crossref","first-page":"e455","DOI":"10.1016\/S2589-7500(22)00062-0","article-title":"Developing and validating a machine-learning algorithm to predict opioid overdose in Medicaid beneficiaries in two US states: A prognostic modelling study","volume":"4","author":"Lo-Ciganic","year":"2022","journal-title":"Lancet Digital Health"},{"issue":"7","key":"10.1016\/j.josat.2026.210065_bb0390","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235981","article-title":"Using machine learning to predict risk of incident opioid use disorder among fee-for-service Medicare beneficiaries: A prognostic study","volume":"15","author":"Lo-Ciganic","year":"2020","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.josat.2026.210065_bb0395","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.0968","article-title":"Evaluation of machine-learning algorithms for predicting opioid overdose risk among Medicare beneficiaries with opioid prescriptions","volume":"2","author":"Lo-Ciganic","year":"2019","journal-title":"JAMA Network Open"},{"issue":"8","key":"10.1016\/j.josat.2026.210065_bb0400","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1111\/add.70040","article-title":"Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone on treatment interruption: Comparing findings from a reanalysis of the X:BOT RCT and harmonized target trial emulation using population-based observational data","volume":"120","author":"Lodi","year":"2025","journal-title":"Addiction"},{"issue":"7","key":"10.1016\/j.josat.2026.210065_bb0405","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.jval.2017.03.008","article-title":"What is real-world data? A review of definitions based on literature and stakeholder interviews","volume":"20","author":"Makady","year":"2017","journal-title":"Value in Health"},{"issue":"4","key":"10.1016\/j.josat.2026.210065_bb0410","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/add.15731","article-title":"Preventing Overdose Using Information and Data from the Environment (PROVIDENT): Protocol for a randomized, population-based, community intervention trial","volume":"117","author":"Marshall","year":"2022","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.josat.2026.210065_bb0415","doi-asserted-by":"crossref","DOI":"10.1186\/s12954-025-01247-3","article-title":"Rural community-based participatory research with families of people who use drugs: Key considerations from a multi-provincial research partnership","volume":"22","author":"Mathias","year":"2025","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.josat.2026.210065_bb0420","article-title":"Target trial emulation: Applying principles of randomised trials to observational studies","volume":"378","author":"Matthews","year":"2022","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.josat.2026.210065_bb0425","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jclinepi.2013.08.015","article-title":"Systematic review of the Hawthorne effect: New concepts are needed to study research participation effects","volume":"67","author":"McCambridge","year":"2014","journal-title":"Journal of Clinical Epidemiology"},{"issue":"11","key":"10.1016\/j.josat.2026.210065_bb0430","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1001\/jamapsychiatry.2022.2756","article-title":"Estimating the prevalence of substance use disorders in the US using the benchmark multiplier method","volume":"79","author":"Mojtabai","year":"2022","journal-title":"JAMA Psychiatry"},{"issue":"6","key":"10.1016\/j.josat.2026.210065_bb0435","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-1878","article-title":"National trends in the prevalence and treatment of depression in adolescents and young adults","volume":"138","author":"Mojtabai","year":"2016","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.josat.2026.210065_bb0440","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-098318","article-title":"Comparative effectiveness of missed dose protocols of opioid agonist treatment in British Columbia, Canada: Protocol for a population-based target trial emulation","volume":"15","author":"Mondol","year":"2025","journal-title":"BMJ Open"},{"key":"10.1016\/j.josat.2026.210065_bb0445","article-title":"Effectiveness of slow-release oral morphine versus other OAT regimens in key sub-populations: Protocol for population-based target trial emulation","author":"Mondol","year":"2025","journal-title":"medRxiv"},{"key":"10.1016\/j.josat.2026.210065_bb0455","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jsat.2017.07.001","article-title":"Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population","volume":"85","author":"Morgan","year":"2018","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2026.210065_bb0460","author":"Network NDATCT"},{"issue":"1","key":"10.1016\/j.josat.2026.210065_bb0465","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/cpt.2410","article-title":"Evolving acceptance and use of RWE for regulatory decision making on the benefit\/risk assessment of a drug in Japan","volume":"111","author":"Nishioka","year":"2022","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"1","key":"10.1016\/j.josat.2026.210065_bb0470","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1037\/ser0000099","article-title":"Development and applications of the Veterans Health Administration\u2019s Stratification Tool for Opioid Risk Mitigation (STORM) to improve opioid safety and prevent overdose and suicide","volume":"14","author":"Oliva","year":"2017","journal-title":"Psychological Services"},{"issue":"4","key":"10.1016\/j.josat.2026.210065_bb0475","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.mcna.2018.02.004","article-title":"Addressing unhealthy substance use in primary care","volume":"102","author":"Pace","year":"2018","journal-title":"The Medical Clinics of North America."},{"issue":"6","key":"10.1016\/j.josat.2026.210065_bb0480","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/MLR.0b013e31824ebd81","article-title":"Doctor and pharmacy shopping for controlled substances","volume":"50","author":"Peirce","year":"2012","journal-title":"Medical Care"},{"key":"10.1016\/j.josat.2026.210065_bb0485","author":"Quality AfHRa"},{"key":"10.1016\/j.josat.2026.210065_bb0490","author":"Quality AfHRa"},{"issue":"9","key":"10.1016\/j.josat.2026.210065_bb0495","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/j.1526-4637.2012.01450.x","article-title":"A model to identify patients at risk for prescription opioid abuse, dependence, and misuse","volume":"13","author":"Rice","year":"2012","journal-title":"Pain Medicine"},{"issue":"3","key":"10.1016\/j.josat.2026.210065_bb0500","doi-asserted-by":"crossref","DOI":"10.2196\/23456","article-title":"Natural language processing of clinical notes to identify mental illness and substance use among people living with HIV: Retrospective cohort study","volume":"9","author":"Ridgway","year":"2021","journal-title":"JMIR Medical Informatics"},{"issue":"1","key":"10.1016\/j.josat.2026.210065_bb0505","doi-asserted-by":"crossref","DOI":"10.1017\/cts.2024.621","article-title":"Accelerating evidence generation: Addressing critical challenges and charting a path forward","volume":"8","author":"Rim","year":"2024","journal-title":"Journal of Clinical and Translational Science"},{"issue":"9","key":"10.1016\/j.josat.2026.210065_bb0510","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/0270-0255(86)90088-6","article-title":"A new approach to causal inference in mortality studies with a sustained exposure period\u2014Application to control of the healthy worker survivor effect","volume":"7","author":"Robins","year":"1986","journal-title":"Mathematical Modelling"},{"issue":"9","key":"10.1016\/j.josat.2026.210065_bb0515","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1007\/s11606-018-4532-5","article-title":"Potentially inappropriate opioid prescribing, overdose, and mortality in Massachusetts, 2011\u20132015","volume":"33","author":"Rose","year":"2018","journal-title":"Journal of General Internal Medicine"},{"issue":"9","key":"10.1016\/j.josat.2026.210065_bb0520","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/jamainternmed.2025.2535","article-title":"Clinical decision support system for primary care of opioid use disorder: A randomized clinical trial","volume":"185","author":"Rossom","year":"2025","journal-title":"JAMA Internal Medicine"},{"issue":"1","key":"10.1016\/j.josat.2026.210065_bb0525","doi-asserted-by":"crossref","DOI":"10.1186\/s13722-021-00245-7","article-title":"A pilot study of the functionality and clinician acceptance of a clinical decision support tool to improve primary care of opioid use disorder","volume":"16","author":"Rossom","year":"2021","journal-title":"Addiction Science & Clinical Practice"},{"issue":"5","key":"10.1016\/j.josat.2026.210065_bb0530","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1037\/h0037350","article-title":"Estimating causal effects of treatments in randomized and nonrandomized studies","volume":"66","author":"Rubin","year":"1974","journal-title":"Journal of Educational Psychology"},{"issue":"2","key":"10.1016\/j.josat.2026.210065_bb0535","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.amepre.2007.04.007","article-title":"Limitations of the randomized controlled trial in evaluating population-based health interventions","volume":"33","author":"Sanson-Fisher","year":"2007","journal-title":"American Journal of Preventive Medicine"},{"key":"10.1016\/j.josat.2026.210065_bb0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109712","article-title":"Cessation of self-reported opioid use and impacts on co-occurring health conditions","volume":"242","author":"Scheidell","year":"2023","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.josat.2026.210065_bb0545","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/aje\/kwab279","article-title":"Identifying predictors of opioid overdose death at a neighborhood level with machine learning","volume":"191","author":"Schell","year":"2022","journal-title":"American Journal of Epidemiology"},{"issue":"3","key":"10.1016\/j.josat.2026.210065_bb0550","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/jamia\/ocaa296","article-title":"Clinician involvement in research on machine learning-based predictive clinical decision support for the hospital setting: A scoping review","volume":"28","author":"Schwartz","year":"2021","journal-title":"Journal of the American Medical Informatics Association"},{"key":"10.1016\/j.josat.2026.210065_bb0555","series-title":"Accidental overdose deaths in Allegheny County, January 2016\u2013June 2020","author":"Services ACDoHaH","year":"2020"},{"key":"10.1016\/j.josat.2026.210065_bb0560","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.genhosppsych.2025.06.010","article-title":"Risk of self-harm and overdose after starting buprenorphine for opioid use disorder","volume":"96","author":"Simon","year":"2025","journal-title":"General Hospital Psychiatry"},{"issue":"2","key":"10.1016\/j.josat.2026.210065_bb0565","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.pop.2014.02.002","article-title":"Prevention and screening, brief intervention, and referral to treatment for substance use in primary care","volume":"41","author":"Strobbe","year":"2014","journal-title":"Primary Care"},{"issue":"2","key":"10.1016\/j.josat.2026.210065_bb0570","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.pain.2010.05.020","article-title":"Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and medicaid insurance plans: The TROUP Study","volume":"150","author":"Sullivan","year":"2010","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.josat.2026.210065_bb0575","doi-asserted-by":"crossref","DOI":"10.1186\/s13722-021-00238-6","article-title":"The NIDA clinical trials network: Evolving, expanding, and addressing the opioid epidemic","volume":"16","author":"Tai","year":"2021","journal-title":"Addiction Science & Clinical Practice"},{"key":"10.1016\/j.josat.2026.210065_bb0580","doi-asserted-by":"crossref","DOI":"10.2196\/37805","article-title":"Practical considerations for developing clinical natural language processing systems for population health management and measurement","volume":"11","author":"Tamang","year":"2023","journal-title":"JMIR Medical Informatics"},{"issue":"12","key":"10.1016\/j.josat.2026.210065_bb0585","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/jamapsychiatry.2017.3206","article-title":"Effectiveness of injectable extended-release naltrexone vs daily buprenorphine-naloxone for opioid dependence: A randomized clinical noninferiority trial","volume":"74","author":"Tanum","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.josat.2026.210065_bb0590","doi-asserted-by":"crossref","DOI":"10.1186\/s12954-022-00615-7","article-title":"The generative potential of mess in community-based participatory research with young people who use(d) drugs in Vancouver","volume":"19","author":"Thulien","year":"2022","journal-title":"Harm Reduction Journal"},{"issue":"6","key":"10.1016\/j.josat.2026.210065_bb0595","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/add.16147","article-title":"Comprehensive needle and syringe program and opioid agonist therapy reduce HIV and hepatitis c virus acquisition among people who inject drugs in different settings: A pooled analysis of emulated trials","volume":"118","author":"van Santen","year":"2023","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.josat.2026.210065_bb0600","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jpainsymman.2020.04.035","article-title":"Time trends in opioid prescribing and uncontrolled pain in the last month of life, 2010-2018 (103C)","volume":"60","author":"Wachterman","year":"2020","journal-title":"Journal of Pain and Symptom Management"},{"issue":"9","key":"10.1016\/j.josat.2026.210065_bb0605","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.35247","article-title":"Semaglutide and opioid overdose risk in patients with type 2 diabetes and opioid use disorder","volume":"7","author":"Wang","year":"2024","journal-title":"JAMA Network Open"},{"issue":"Suppl. 2","key":"10.1016\/j.josat.2026.210065_bb0610","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1111\/j.1526-4637.2011.01134.x","article-title":"An analysis of the root causes for opioid-related overdose deaths in the United States","volume":"12","author":"Webster","year":"2011","journal-title":"Pain Medicine"},{"issue":"6","key":"10.1016\/j.josat.2026.210065_bb0615","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/jama.2018.20404","article-title":"Performance of the centers for Medicare & Medicaid services\u2019 opioid overutilization criteria for classifying opioid use disorder or overdose","volume":"321","author":"Wei","year":"2019","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.josat.2026.210065_bb0620","first-page":"897","article-title":"Analytic models to identify patients at risk for prescription opioid abuse","volume":"15","author":"White","year":"2009","journal-title":"The American Journal of Managed Care"},{"issue":"8","key":"10.1016\/j.josat.2026.210065_bb0625","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-095461","article-title":"Comparative effectiveness of methadone versus buprenorphine\/naloxone during pregnancy on perinatal and neonatal health outcomes: Protocol for a population-based target trial in British Columbia, Canada","volume":"15","author":"Wilson","year":"2025","journal-title":"BMJ Open"},{"issue":"9","key":"10.1016\/j.josat.2026.210065_bb0630","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2025-098990","article-title":"Comparative effectiveness of alternative initial doses of opioid agonist treatment for individuals with opioid use disorder: A protocol for a retrospective population-based study using target trial emulation in British Columbia, Canada","volume":"15","author":"Yan","year":"2025","journal-title":"BMJ Open"},{"issue":"8","key":"10.1016\/j.josat.2026.210065_bb0635","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-098439","article-title":"Comparative effectiveness of maintenance doses of opioid agonist treatment among individuals with opioid use disorder: A target trial emulation protocol using a population-based observational study","volume":"15","author":"Zanette","year":"2025","journal-title":"BMJ Open"},{"issue":"8","key":"10.1016\/j.josat.2026.210065_bb0640","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1111\/pme.12777","article-title":"Development of a risk index for serious prescription opioid-induced respiratory depression or overdose in Veterans\u2019 Health Administration patients","volume":"16","author":"Zedler","year":"2015","journal-title":"Pain Medicine"},{"issue":"1","key":"10.1016\/j.josat.2026.210065_bb0645","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/pm\/pnx009","article-title":"Validation of a screening risk index for serious prescription opioid-induced respiratory depression or overdose in a US commercial health plan claims database","volume":"19","author":"Zedler","year":"2018","journal-title":"Pain Medicine"},{"key":"10.1016\/j.josat.2026.210065_bb0650","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jclinepi.2023.08.003","article-title":"The implementation of target trial emulation for causal inference: A scoping review","volume":"162","author":"Zuo","year":"2023","journal-title":"Journal of Clinical Epidemiology"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875926001852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875926001852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T13:30:22Z","timestamp":1786195822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875926001852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":129,"alternative-id":["S2949875926001852"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2026.210065","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methodological innovations to advance substance use disorder research: Proceedings of a NIDA workshop on target trial emulation and translational testing of digital health tools","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2026.210065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"210065"}}